Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice

British Journal of Cancer

Volumn 108, Issue 11, 2013, Pages 2281-2290

  Chandra, D ^a   Jahangir, A ^a   Quispe Tintaya, W ^a   Einstein, M H ^a   Gravekamp, C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Aging; Immunotherapy; Listeria monocytogenes; Metastatic breast cancer; Myeloid derived suppressor cells

Indexed keywords

INTERLEUKIN 12;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BREAST METASTASIS; CANCER IMMUNOTHERAPY; CD8+ T LYMPHOCYTE; CELL SUBPOPULATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GROUPS BY AGE; LISTERIA MONOCYTOGENES; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIMARY TUMOR; PRIORITY JOURNAL; SUPPRESSOR CELL; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; AGE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; EXPERIMENTAL NEOPLASM; IMMUNOLOGY; IMMUNOTHERAPY; METHODOLOGY; MICROBIOLOGY; T LYMPHOCYTE;

AGE FACTORS; ANIMALS; FEMALE; IMMUNOTHERAPY; INTERLEUKIN-12; KILLER CELLS, NATURAL; LISTERIA MONOCYTOGENES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MYELOID CELLS; T-LYMPHOCYTES;

EID: 84884177601     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.206     Document Type: Article

References (43)

1. Aslakson CJ, Miller FR (1992) Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 52(6): 1399-1405.
2. Castro F, Leal B, Denny A, Bahar R, Lampkin S, Reddick R, Lu S, Gravekamp C (2009) Vaccination with Mage-b DNA induces CD8 T-cell responses at young but not old age in mice with metastatic breast cancer. Br J Cancer 101(8): 1329-1337.
3. De Backer O, Verheyden AM, Martin B, Godelaine D, De Plaen E, Brasseur R, Avner P, Boon T (1995) Structure, chromosomal location, and expression pattern of three mouse genes homologous to the human MAGE genes. Genomics 28(1): 74-83.
4. Diaz-Montero CM, Salem ML, Nishimura MI, Garrett-Mayer E, Cole DJ, Montero AJ (2009) Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother 58(1): 49-59.
5. Extermann M (2011) Basic assessment of the older cancer patient. Curr Treat Options Oncol 12(3): 276-285.
6. Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9(3): 162-174.
7. George AJ, Ritter MA (1996) Thymic involution with ageing: obsolescence or good housekeeping? Immunol Today 17(6): 267-272.
8. Gravekamp C (2011) The impact of aging on cancer vaccination. Curr Opin Immunol 23(4): 555-560.
9. Gravekamp C, Paterson Y (2010) Harnessing Listeria monocytogenes to target tumors. Cancer Biol Ther 9(4): 1-9.
10. Grizzle WE, Xu X, Zhang S, Stockard CR, Liu C, Yu S, Wang J, Mountz JD, Zhang HG (2007) Age-related increase of tumor susceptibility is associated with myeloid-derived suppressor cell mediated suppression of T cell cytotoxicity in recombinant inbred BXD12 mice. Mech Ageing Dev 128(11-12): 672-680.
11. Gunn GR, Zubair A, Peters C, Pan ZK, Wu TC, Paterson Y (2001) Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16. J Immunol 167(11): 6471-6479.
12. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM (1993) Development of TH1 CD4+ T cells through IL-12 produced by Listeriainduced macrophages. Science 260(5107): 547-549.
13. Ilkovitch D, Lopez DM (2009) The liver is a site for tumor-induced myeloidderived suppressor cell accumulation and immunosuppression. Cancer Res 69(13): 5514-5521.
14. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ (2005) Cancer statistics, 2005. CA Cancer J Clin 55(1): 10-30.
15. Kim SH, Castro F, Gonzalez D, Maciag PC, Paterson Y, Gravekamp C (2008) Mage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases. Br J Cancer 99(5): 741-749.
16. Kim SH, Castro F, Paterson Y, Gravekamp C (2009) High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action. Cancer Res 69(14): 5860-5866.
17. Kim TS, Kang BY, Cho D, Kim SH (2003) Induction of interleukin-12 production in mouse macrophages by berberine, a benzodioxoloquinolizine alkaloid, deviates CD4+ T cells from a Th2 to a Th1 response. Immunology 109(3): 407-414.
18. Lefebvre JS, Maue AC, Eaton SM, Lanthier PA, Tighe M, Haynes L (2012) The aged microenvironment contributes to the age-related functional defects of CD4 T cells in mice. Aging cell 11(5): 732-740.
19. Li G, Smithey MJ, Rudd BD, Nikolich-Zugich J (2012) Age-associated alterations in CD8alpha+ dendritic cells impair CD8 T-cell expansion in response to an intracellular bacterium. Aging cell 11(6): 968-977.
20. Lustgarten J, Dominguez AL, Thoman M (2004) Aged mice develop protective antitumor immune responses with appropriate costimulation. J Immunol 173(7): 4510-4515.
21. Maciag PC, Radulovic S, Rothman J (2009) The first clinical use of a liveattenuated Listeria monocytogenes vaccine: a Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix. Vaccine 27(30): 3975-3983.
22. Miller RA (1996) The aging immune system: primer and prospectus. Science 273(5271): 70-74.
23. Movahedi K, Guilliams M, Van den Bossche J, Van den Bergh R, Gysemans C, Beschin A, De Baetselier P, Van Ginderachter JA (2008) Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111(8): 4233-4244.
24. Muraille E, Narni-Mancinelli E, Gounon P, Bassand D, Glaichenhaus N, Lenz LL, Lauvau G (2007) Cytosolic expression of SecA2 is a prerequisite for long-term protective immunity. Cell Microbiol 9(6): 1445-1454.
25. Ostrand-Rosenberg S, Sinha P (2009) Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 182(8): 4499-4506.
26. Pan ZK, Weiskirch LM, Paterson Y (1999) Regression of established B16F10 melanoma with a recombinant Listeria monocytogenes vaccine. Cancer Res 59(20): 5264-5269.
27. Portnoy DA, Auerbuch V, Glomski IJ (2002) The cell biology of Listeria monocytogenes infection: the intersection of bacterial pathogenesis and cell-mediated immunity. J Cell Biol 158(3): 409-414.
28. Provinciali M, Argentati K, Tibaldi A (2000) Efficacy of cancer gene therapy in aging: adenocarcinoma cells engineered to release IL-2 are rejected but do not induce tumor specific immune memory in old mice. Gene Ther 7(7): 624-632.
29. Provinciali M, Barucca A, Pierpaoli E, Orlando F, Pierpaoli S, Smorlesi A (2012) In vivo electroporation restores the low effectiveness of DNA vaccination against HER-2/neu in aging. Cancer Immunol Immunother 61(3): 363-371.
30. Provinciali M, Smorlesi A, Donnini A, Bartozzi B, Amici A (2003) Low effectiveness of DNA vaccination against HER-2/neu in ageing. Vaccine 21(9-10): 843-848.
31. Pylayeva-Gupta Y, Lee KE, Hajdu CH, Miller G, Bar-Sagi D (2012) Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell 21(6): 836-847.
32. Racz P, Tenner K, Mero E (1972) Experimental Listeria enteritis. I. An electron microscopic study of the epithelial phase in experimental listeria infection. Lab Invest 26(6): 694-700.
33. Rosen H, Gordon S (1987) Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo. J Exp Med 166(6): 1685-1701.
34. Seavey MM, Pan ZK, Maciag PC, Wallecha A, Rivera S, Paterson Y, Shahabi V (2009) A novel human Her-2/neu chimeric molecule expressed by Listeria monocytogenes can elicit potent HLA-A2 restricted CD8-positive T cell responses and impact the growth and spread of Her-2/neu-positive breast tumors. Clin Cancer Res 15(3): 924-932.
35. Sharma S, Dominguez AL, Lustgarten J (2006) High accumulation of T regulatory cells prevents the activation of immune responses in aged animals. J Immunol 177(12): 8348-8355.
36. Singh R, Dominiecki ME, Jaffee EM, Paterson Y (2005) Fusion to Listeriolysin O and delivery by Listeria monocytogenes enhances the immunogenicity of HER-2/neu and reveals subdominant epitopes in the FVB/N mouse. J Immunol 175(6): 3663-3673.
37. Sinha P, Chornoguz O, Clements VK, Artemenko KA, Zubarev RA, Ostrand-Rosenberg S (2011) Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL. Blood 117(20): 5381-5390.
38. Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA (2009) Future of cancer incidence in the United States: burdens upon an aging, changing. J Clin Oncol 27(17): 2758-2765.
39. Utsuyama M, Hirokawa K, Kurashima C, Fukayama M, Inamatsu T, Suzuki K, Hashimoto W, Sato K (1992) Differential age-change in the numbers of CD4+CD45RA+ and CD4+CD29+ T cell subsets in human peripheral blood. Mech Ageing Dev 63(1): 57-68.
40. Valenzuela J, Schmidt C, Mescher M (2002) The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells. J Immunol 169(12): 6842-6849.
41. Weinberger B, Grubeck-Loebenstein B (2012) Vaccines for the elderly. Clin Microbiol Infect 18(Suppl 5): 100-108.
42. Youn JI, Nagaraj S, Collazo M, Gabrilovich DI (2008) Subsets of myeloidderived suppressor cells in tumor-bearing mice. J Immunol 181(8): 5791-5802.
43. Zenewicz LA, Shen H (2007) Innate and adaptive immune responses to Listeria monocytogenes: a short overview. Microbes Infect 9(10): 1208-1215.